Host defense in cryptococcosis. III. In vivo alteration of immunity
β Scribed by John Richard Graybill; Linda Mitchell
- Publisher
- Springer Netherlands
- Year
- 1979
- Tongue
- English
- Weight
- 616 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0301-486X
No coin nor oath required. For personal study only.
β¦ Synopsis
The present studies utilize an inbred mouse model to evaluate the adoptive transfer of spleen cells to augment immunity against Cryptococcus neoformans. Protection against cryptococcosis was transferred using spleen cells obtained from mice surviving cryptococcosis. These spleen cell donors had no detectable anticryptococcal antibody. Also, treatment with antimouse-thymocyte globulin ablated dermal hypersensitivity reactions of immunized mice, and shortened survival in both immunized and unimmunized mice. These in vivo studies further support a major role for cell-mediated immunity in host defense against experimental cryptococcosis.
π SIMILAR VOLUMES
Escape from the immune surveillance may play an important role in tumor outgrowth and metastasis. Alteration of the Fas receptor (Fas)/ligand (FasL) system including soluble forms is regarded as one of the mechanisms preventing the immune system from rejecting the tumor cells. However, less attentio
Possible mechanisms of natural defense against a nonimmunogenic, nonlymphoid rat tumor were evaluated in vitro and examined for effectivity in vivo, using BSp6S, the subcutaneously grown transplantation line of a spontaneously arising fibrosarcoma in the BDX rat strain, whieh is highly susceptible t
It was evaluated in vitro whether it is possible to induce immunogenicity by haptenization of a nonlymphoid rat tumor, BSp6AS, which is known to be antigenic, but nonimmunogenic, in the syngeneic host. The effectivity of "induced immunogenicity' was tested in vivo. BSp6AS, an NK-and macrophage-resi